These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38114000)

  • 1. Pre-exposure prophylactic mucoadhesive sodium alginate microsphere laden pessaries for intravaginal delivery of tenofovir disoproxil fumarate.
    Avlani D; Shivakumar HN; Kumar A; Prajila A; Baraka BBH; Bhagya V
    Int J Biol Macromol; 2024 Feb; 258(Pt 1):128816. PubMed ID: 38114000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Dispersible Vaginal Tablets of Tenofovir Loaded Mucoadhesive Chitosan Microparticles for Anti-HIV Pre-Exposure Prophylaxis.
    Avlani D; Kumar A; H N S
    Mol Pharm; 2023 Oct; 20(10):5006-5018. PubMed ID: 37656937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of mucoadhesive vaginal tablets of tenofovir disoproxil fumarate for pre-exposure prophylaxis of HIV.
    Khan AB; Thakur RS
    Drug Dev Ind Pharm; 2018 Mar; 44(3):472-483. PubMed ID: 29082767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of mucoadhesive microspheres of tenofovir disoproxil fumarate for intravaginal use.
    Khan AB; Thakur RS
    Curr Drug Deliv; 2014; 11(1):112-22. PubMed ID: 24171706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate.
    Baum MM; Butkyavichene I; Churchman SA; Lopez G; Miller CS; Smith TJ; Moss JA
    Int J Pharm; 2015 Nov; 495(1):579-587. PubMed ID: 26386138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of tenofovir release from mucoadhesive vaginal tablets by polymer combination to prevent sexual transmission of HIV.
    Notario-Pérez F; Cazorla-Luna R; Martín-Illana A; Ruiz-Caro R; Tamayo A; Rubio J; Veiga MD
    Carbohydr Polym; 2018 Jan; 179():305-316. PubMed ID: 29111056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.
    Smith JM; Rastogi R; Teller RS; Srinivasan P; Mesquita PM; Nagaraja U; McNicholl JM; Hendry RM; Dinh CT; Martin A; Herold BC; Kiser PF
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16145-50. PubMed ID: 24043812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vitro evaluation of diclofenac sodium loaded mucoadhesive microsphere with natural gum for sustained delivery.
    Amin ML; Jesmeen T; Sutradhar KB; Mannan MA
    Curr Drug Deliv; 2013 Dec; 10(6):765-70. PubMed ID: 23937160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrospun fibers for vaginal administration of tenofovir disoproxil fumarate and emtricitabine in the context of topical pre-exposure prophylaxis.
    Nunes R; Bogas S; Faria MJ; Gonçalves H; Lúcio M; Viseu T; Sarmento B; das Neves J
    J Control Release; 2021 Jun; 334():453-462. PubMed ID: 33961916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-emulsified Alginate-Eudragit Nanoparticles: Potential Carriers for Localized and Time-defined Release of Tenofovir in the Female Genital Tract.
    Takalani F; Kumar P; Kondiah PPD; Choonara YE
    AAPS PharmSciTech; 2024 Jan; 25(1):15. PubMed ID: 38200167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
    Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Pyles RB; Guthrie KM; Dawson L; Olive TJ; Butkyavichene I; Churchman SA; Cortez JM; Fanter R; Gunawardana M; Miller CS; Yang F; Rosen RK; Vargas SE; Baum MM
    PLoS Med; 2018 Sep; 15(9):e1002655. PubMed ID: 30265679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of Tenofovir vaginal release from hydrophilic matrices through drug granulation with hydrophobic polymers.
    Notario-Pérez F; Martín-Illana A; Cazorla-Luna R; Ruiz-Caro R; Peña J; Veiga MD
    Eur J Pharm Sci; 2018 May; 117():204-215. PubMed ID: 29477644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal Polyelectrolyte Layer-by-Layer Films Based on Chitosan Derivatives and Eudragit
    Cazorla-Luna R; Martín-Illana A; Notario-Pérez F; Bedoya LM; Tamayo A; Ruiz-Caro R; Rubio J; Veiga MD
    Mar Drugs; 2020 Jan; 18(1):. PubMed ID: 31936439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioadhesive vaginal tablets containing spray dried microspheres loaded with clotrimazole for treatment of vaginal candidiasis.
    Gupta NV; Natasha S; Getyala A; Bhat RS
    Acta Pharm; 2013 Sep; 63(3):359-72. PubMed ID: 24152896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a mucoadhesive dosage form for vaginal administration.
    Ceschel GC; Maffei P; Lombardi Borgia S; Ronchi C; Rossi S
    Drug Dev Ind Pharm; 2001 Jul; 27(6):541-7. PubMed ID: 11548861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoadhesive tablets for the vaginal delivery of progesterone: in vitro evaluation and pharmacokinetics/pharmacodynamics in female rabbits.
    Hassan AS; Soliman GM; Ali MF; El-Mahdy MM; El-Gindy GEA
    Drug Dev Ind Pharm; 2018 Feb; 44(2):224-232. PubMed ID: 28956650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of a Tenofovir Disoproxil Fumarate Intravaginal Ring for HIV Pre-Exposure Prophylaxis Among Sexually Active Women.
    Dobkin A; McWalters J; Barnett R; Ray LL; Espinoza L; McGinn AP; Atrio JM; Keller MJ
    Sex Transm Dis; 2020 Dec; 47(12):819-824. PubMed ID: 33186337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.
    Shadab ; Ahuja A; Khar RK; Baboota S; Chuttani K; Mishra AK; Ali J
    Drug Deliv; 2011 May; 18(4):255-64. PubMed ID: 21110695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
    Amin MK; Boateng JS
    Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
    [No Abstract]   [Full Text] [Related]  

  • 20. Genital Mucosal Drug Concentrations and anti-HIV Activity in Tenofovir-Based PrEP Products: Intravaginal Ring vs. Oral Administration.
    Ouattara LA; Thurman AR; Jacot TA; Cottrell M; Sykes C; Blake K; Fang X; Ju S; Vann NC; Schwartz J; Doncel GF
    J Acquir Immune Defic Syndr; 2022 Jan; 89(1):87-97. PubMed ID: 34878438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.